Top Biotechnology & Medical Research stocks in United States

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name
Market Cap
Price to Earnings
TTM
Dividend Yield
% TTM
us flag iconREGNRegeneron Pharmaceuticals$105.86bn26.49n/a
us flag iconVRTXVertex Pharmaceuticals$105.31bn29.34n/a
us flag iconIQVIqvia Holdings$45.87bn32.65n/a
us flag iconSGENSeagen$43.15bnn/an/a
us flag iconMRNAModerna$39.68bnn/an/a
us flag iconICLRIcon$27.62bn39.55n/a
us flag iconBNTXBioNTech SE$21.98bn7.56n/a
us flag iconALNYAlnylam Pharmaceuticals$18.80bnn/an/a
us flag iconNBIXNeurocrine Biosciences$13.84bn39.25n/a
us flag iconCRLCharles River Laboratories International$13.30bn32.71n/a
us flag iconKRTXKaruna Therapeutics$12.58bnn/an/a
us flag iconMEDPMedpace Holdings$12.20bn44.7n/a
us flag iconSRPTSarepta Therapeutics$11.55bnn/an/a
us flag iconTECHBIO-TECHNE$11.40bn50.370.44%
us flag iconUTHRUnited Therapeutics$11.10bn11.87n/a
us flag iconLEGNLegend Biotech$10.57bnn/an/a
us flag iconEXASExact Sciences$10.48bnn/an/a
us flag iconQGENQiagen NV$9.75bn26.44n/a
us flag iconRXDXPrometheus Biosciences$9.56bnn/an/a
us flag iconIMGNImmunoGen$8.72bnn/an/a